NASDAQ · Biotechnology

ELTX (ELTX) Stock

$2.56 -5.19% NASDAQ: ELTX Healthcare

Valuation

MetricValue
Price$2.56
Market Cap$48.81M
P/E Ratio-1.47
P/B Ratio7.59
P/S Ratio0.00
EPS (TTM)$-2.58
52-Week High$16.00
52-Week Low$2.56
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-977.67%
ROA-120.78%
ROCE-171.36%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity1.78
Current Ratio2.38

Annual Financials (USD)

Metric20212022202320242025
Revenue$28.0M$0$0$0$0
Operating Profit$-39.0M$-24.0M$-36.0M$-45.0M$-38.0M
Net Profit$-26.0M$-28.0M$-35.0M$-52.0M$-40.0M
EPS$-19.32$-9.10$-6.96$-4.25$-2.58
Op Margin-138.8%————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$97.0M$23.0M$27.0M$28.0M$26.0M
Total Liabilities$15.0M$14.0M$16.0M$39.0M$24.0M
Cash$89.0M$8.0M$13.0M$18.0M$19.0M
Borrowings$5.0M$7.0M$7.0M$26.0M$15.0M

Latest News

Elicio Therapeutics Closes $15 Million Registered Direct Offering MT Newswires · Jul 6, 2026 Elicio Therapeutics Announces Closing of $15 Million Registered Direct Offering GlobeNewswire · Jul 6, 2026 Top Midday Decliners MT Newswires · Jul 2, 2026 Wall Street Set to Open Higher in Thursday Trading; US Adds Only 57,000 Jobs in June MT Newswires · Jul 2, 2026 Top Premarket Decliners MT Newswires · Jul 2, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-24.0M$-22.0M$-33.0M$-37.0M$-37.0M
Investing Cash Flow$-1.0M$-1.0M$0$0$0
Financing Cash Flow$0$0$22.0M$17.0M$0
Net Cash Flow$-5.0M$-81.0M$6.0M$5.0M$0
Free Cash Flow$-24.0M$-23.0M$-33.0M$-37.0M$-37.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.02
EV / EBITDA-1.24
FCF Yield-63.19%
Quick Ratio2.77
Interest Coverage-24.00
Return 1Y-67.19%
Return 3Y-70.81%
Return 5Y-97.22%

Ownership

Insiders Held24.68%
Institutions Held16.85%
Institutions Float Held22.38%
Institutional HolderSharesReport Date
Knoll Capital Management, LLC630,9152026-03-31
Vanguard Capital Management LLC518,6382026-03-31
Balyasny Asset Management LP244,8142026-03-31
Geode Capital Management, LLC135,1642026-03-31
Renaissance Technologies, LLC121,6312026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACTU $1.54 +1.32% -2.73 $36.85M 0.00%
APLTApplied Therapeutics, Inc. $0.10 +0.00% -0.24 $14.86M 0.00%
CRBP $11.28 +3.39% -1.95 $208.99M 0.00%
CRDF $1.03 +3.66% -2.58 $79.39M 0.00%
MIST $1.14 -1.72% -2.00 $141.93M 0.00%

About ELTX

ELTX is led by CEO Robert T. Connelly, employs 32 people, headquartered in US, publicly traded since 2021.

ELTX stock trades at $2.56 with a market capitalization of $48.81M. The stock is valued at a price-to-earnings (P/E) ratio of -1.47, price-to-book of 7.59, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $2.56 and $16.00, and currently trades 84.0% below its 52-week high.

On profitability, ELTX generates a return on equity (ROE) of -977.67%, return on capital employed of -171.36%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1159.93 +0.28% JNJ Drug Manufacturers - General $271.19 +2.01% ABBV Drug Manufacturers - General $259.99 +1.39% MRK Drug Manufacturers - General $149.94 +1.48% UNH Medical - Healthcare Plans $396.30 +1.77% NVS Drug Manufacturers - General $161.25 +6.04% AZN Drug Manufacturers - General $162.47 +0.21% AMGN Drug Manufacturers - General $438.12 +1.92% TMO Medical - Diagnostics & Research $600.50 -2.69% NVO Biotechnology $45.12 -0.46% ABT Medical - Devices $108.97 -1.26% GILD Drug Manufacturers - General $149.92 +2.45%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides